Literature DB >> 18465867

General, robust, and stereocomplementary preparation of beta-ketoester enol tosylates as cross-coupling partners utilizing TsCl-N-methylimidazole agents.

Hidefumi Nakatsuji1, Kanako Ueno, Tomonori Misaki, Yoo Tanabe.   

Abstract

We have developed a general, robust, and cost-effective method for the (E)- or (Z)-stereocomplementary enol tosylation of beta-ketoesters using TsCl- N-methylimidazole (NMI)-Et3N or LiOH. TsCl coupled with NMI formed a highly reactive N-sulfonylammonium intermediate. Stereocongested secondary alcohols were smoothly sulfonylated using Ts(Ms)Cl-NMI-Et3N. beta-Ketoesters underwent (E)-selective tosylation using TsCl-NMI-Et3N and (Z)-selective tosylation using TsCl-NMI-LiOH (total of 23 examples; 60%-99% yield). Stereoretentive Negishi and Sonogashira couplings using enol tosylates proceeded successfully to give trisubstituted alpha,beta-unsaturated esters.

Entities:  

Year:  2008        PMID: 18465867     DOI: 10.1021/ol800480d

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  4 in total

1.  Nickel-catalyzed reductive arylation of activated alkynes with aryl iodides.

Authors:  Stephanie C M Dorn; Andrew K Olsen; Rachel E Kelemen; Ruja Shrestha; Daniel J Weix
Journal:  Tetrahedron Lett       Date:  2015-06-03       Impact factor: 2.415

2.  Efficient Pd-catalyzed coupling of tautomerizable heterocycles with terminal alkynes via C-OH bond activation using PyBrOP.

Authors:  Ce Shi; Courtney C Aldrich
Journal:  Org Lett       Date:  2010-05-21       Impact factor: 6.005

3.  Divergent Synthetic Access to E- and Z-Stereodefined All-Carbon-Substituted Olefin Scaffolds: Application to Parallel Synthesis of (E)- and (Z)-Tamoxifens.

Authors:  Yuichiro Ashida; Atsushi Honda; Yuka Sato; Hidefumi Nakatsuji; Yoo Tanabe
Journal:  ChemistryOpen       Date:  2017-01-18       Impact factor: 2.911

Review 4.  Pd-Catalyzed Cross-Couplings: On the Importance of the Catalyst Quantity Descriptors, mol % and ppm.

Authors:  Christopher S Horbaczewskyj; Ian J S Fairlamb
Journal:  Org Process Res Dev       Date:  2022-07-11       Impact factor: 3.858

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.